Syncom Healthcare has informed that the meeting of the Board of Directors of the Company is scheduled to be held on February 14, 2017, to consider and take on record the unaudited financial results of the Company for the quarter and nine months ended December 31, 2016 (Q3). Further, as per the ‘code of conduct’ formed under Securities and Exchange Board of India (Prohibition of Insider Trading ) Regulations ,2015, the trading window will be closed from 7th February 2017 till forty eight hours after the declaration of the results for Directors, KMP, officers and Designated employees and their immediate relatives.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: